FR13C0049I1 - - Google Patents

Info

Publication number
FR13C0049I1
FR13C0049I1 FR13C0049C FR13C0049I1 FR 13C0049 I1 FR13C0049 I1 FR 13C0049I1 FR 13C0049 C FR13C0049 C FR 13C0049C FR 13C0049 I1 FR13C0049 I1 FR 13C0049I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR13C0049(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR13C0049I1 publication Critical patent/FR13C0049I1/fr
Application granted granted Critical
Publication of FR13C0049I2 publication Critical patent/FR13C0049I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR13C0049C 1995-09-05 2013-08-13 NEW 1-AR(ALK)YL-IMIDAZOLIN-2-ONES WITH ANTICONVULSIVE EFFECT CONTAINING A BISUBSTITUTED AMINE REST IN POSITION 4 AND METHOD FOR PREPARING THEM Active FR13C0049I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (en) 1995-09-05 1995-09-05 Novel, anticonvulsant 1-ar (alk) yl-imidazolin-2-ones which contain a disubstituted amine radical in the 4-position, and process for their preparation
PCT/EP1996/003295 WO1997009314A1 (en) 1995-09-05 1996-07-26 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production

Publications (2)

Publication Number Publication Date
FR13C0049I1 true FR13C0049I1 (en) 2013-09-27
FR13C0049I2 FR13C0049I2 (en) 2014-03-28

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
FR13C0049C Active FR13C0049I2 (en) 1995-09-05 2013-08-13 NEW 1-AR(ALK)YL-IMIDAZOLIN-2-ONES WITH ANTICONVULSIVE EFFECT CONTAINING A BISUBSTITUTED AMINE REST IN POSITION 4 AND METHOD FOR PREPARING THEM

Country Status (32)

Country Link
EP (1) EP0863880B1 (en)
JP (1) JP4030578B2 (en)
CN (1) CN1103762C (en)
AR (1) AR003502A1 (en)
AT (1) ATE254606T1 (en)
AU (1) AU700602B2 (en)
BG (1) BG63917B1 (en)
BR (1) BR9610359A (en)
CA (1) CA2184871C (en)
CZ (1) CZ291839B6 (en)
DE (2) DE19532668A1 (en)
DK (1) DK0863880T3 (en)
EA (1) EA000535B1 (en)
EE (1) EE03562B1 (en)
ES (1) ES2208758T3 (en)
FR (1) FR13C0049I2 (en)
GE (1) GEP20022652B (en)
HK (1) HK1015776A1 (en)
HU (1) HU225956B1 (en)
IL (1) IL123333A (en)
LT (1) LT4482B (en)
LU (1) LU92263I2 (en)
NO (1) NO313829B1 (en)
NZ (1) NZ315624A (en)
PL (1) PL188287B1 (en)
PT (1) PT863880E (en)
SK (1) SK284868B6 (en)
TR (1) TR199800476T1 (en)
TW (1) TW422838B (en)
UA (1) UA46790C2 (en)
WO (1) WO1997009314A1 (en)
ZA (1) ZA967014B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (en) * 1997-05-23 1998-11-26 Dresden Arzneimittel Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
CN101254189A (en) * 2003-07-11 2008-09-03 埃尔比昂股份公司 Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
BR112014003117A2 (en) 2011-08-12 2017-06-13 Boehringer Ingelheim Vetmedica Gmbh funny (if) current inhibitors for use in a method of treatment and prevention of feline heart failure
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (en) 2021-01-18 2022-07-18 Procos Spa PROCESS FOR THE SYNTHESIS OF IMEPITOIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (en) 1971-10-21 1973-04-20 American Cyanamid Co NEW (P-CHLORO) PHENYL-1 METHYL-3 IMIDAZOLIDINES, 2,4-DISUBSTITUTIONS USEFUL IN PARTICULAR AS ANTIALDOSTERONE DIURETIC AGENTS AND THEIR PREPARATION PROCESS
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
BG102287A (en) 1998-09-30
NO980906L (en) 1998-03-02
NO980906D0 (en) 1998-03-02
EP0863880A1 (en) 1998-09-16
LT4482B (en) 1999-03-25
JP4030578B2 (en) 2008-01-09
HK1015776A1 (en) 1999-10-22
HUP9802941A3 (en) 1999-10-28
EE9800063A (en) 1998-08-17
FR13C0049I2 (en) 2014-03-28
ATE254606T1 (en) 2003-12-15
DE59610827D1 (en) 2003-12-24
BR9610359A (en) 1999-07-06
MX9801742A (en) 1998-08-30
NO313829B1 (en) 2002-12-09
JPH11512101A (en) 1999-10-19
DE19532668A1 (en) 1997-03-06
CN1103762C (en) 2003-03-26
PL325413A1 (en) 1998-07-20
EA199800271A1 (en) 1998-10-29
LT98047A (en) 1998-10-26
HU225956B1 (en) 2008-01-28
HUP9802941A2 (en) 1999-09-28
DK0863880T3 (en) 2004-03-22
GEP20022652B (en) 2002-03-25
UA46790C2 (en) 2002-06-17
CZ291839B6 (en) 2003-06-18
AR003502A1 (en) 1998-08-05
CN1200728A (en) 1998-12-02
SK284868B6 (en) 2006-01-05
LU92263I2 (en) 2013-10-07
AU6737596A (en) 1997-03-27
TR199800476T1 (en) 1998-06-22
BG63917B1 (en) 2003-06-30
SK21698A3 (en) 1998-10-07
EP0863880B1 (en) 2003-11-19
EE03562B1 (en) 2001-12-17
WO1997009314A1 (en) 1997-03-13
CA2184871C (en) 2001-08-21
IL123333A0 (en) 1998-09-24
ES2208758T3 (en) 2004-06-16
NZ315624A (en) 1998-11-25
IL123333A (en) 2001-10-31
TW422838B (en) 2001-02-21
EA000535B1 (en) 1999-10-28
PL188287B1 (en) 2005-01-31
CZ66198A3 (en) 1998-07-15
AU700602B2 (en) 1999-01-07
CA2184871A1 (en) 1997-03-06
PT863880E (en) 2004-04-30
ZA967014B (en) 1997-08-18

Similar Documents

Publication Publication Date Title
DE69638352D1 (en)
DE69637714D1 (en)
BR122012014331A2 (en)
IN188196B (en)
BRPI9612258B1 (en)
BRPI9612138B1 (en)
FR13C0049I1 (en)
CH0741373H1 (en)
AU1627395A (en)
IN188365B (en)
BR7501503U (en)
BR7502120U (en)
IN183732B (en)
CN3033635S (en)
CN3031742S (en)
CN3035870S (en)
CN3035868S (en)
CN3035323S (en)
CN3034829S (en)
CN3034591S (en)
CN3034524S (en)
CN3034473S (en)
CN3034189S (en)
CN3033771S (en)
CN3036463S (en)